Overview

AZD8683 Multiple Dose Study in Healthy Volunteers and Chronic Obstructive Pulmonary Disease (COPD) Patients

Status:
Terminated
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
This study will investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of multiple ascending inhaled doses of AZD8683 in Healthy volunteers and repeated inhalation of one dose level of AZD8683 in patients with chronic obstructive pulmonary disease given once daily.
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca